Announcements Trials
Browse Landscape

Phase

Phase 3 1

Status

Enrolling by invitation 2Recruiting 1

Sponsor Class

OTHER 3

Study Type

Observational 2Interventional 1

Sponsor

Conditions

Breast Neoplasms 1316Neoplasms 1104Carcinoma, Non-Small-Cell Lung 916Prostatic Neoplasms 747Colorectal Neoplasms 645Lung Neoplasms 621Neoplasm Metastasis 470Multiple Myeloma 444Leukemia, Myeloid, Acute 440Pancreatic Neoplasms 392Ovarian Neoplasms 388Melanoma 346Carcinoma, Hepatocellular 308Brain Neoplasms 290Squamous Cell Carcinoma of Head and Neck 285Recurrence 285Glioblastoma 260Stomach Neoplasms 252Head and Neck Neoplasms 250Precursor Cell Lymphoblastic Leukemia-Lymphoma 238Carcinoma, Renal Cell 237Lymphoma 235Triple Negative Breast Neoplasms 233Endometrial Neoplasms 221Uterine Cervical Neoplasms 217Hematologic Neoplasms 216Urinary Bladder Neoplasms 212Lymphoma, Non-Hodgkin 203Glioma 202Sarcoma 200

Interventions

Blood Specimen Collection 1Adrenal Cortex Hormones 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
Myelitis, Transverse × 90 days × Clear all
NCT00704626 2026-05-18

SAA

University of California, Davis

Enrolling by invitation
120 enrolled

Autoimmune Diseases, Multiple Sclerosis, Myasthenia Gravis, Myelitis, Transverse

NCT07100990 2026-05-05

TIMELY-PLEX

Mayo Clinic

Phase 3 Recruiting
382 enrolled

Myelitis, Myelitis, Transverse, Optic Neuritis

NCT06163508 2026-04-21

A Long Term Follow-Up Study for Subjects Who Have Received Q-Cells

University of Texas Southwestern Medical Center

Enrolling by invitation
9 enrolled

Myelitis, Transverse

Data powered by HemOnc (CC BY 4.0) Colophon âš¡